Catalyst Wire Dossier Catalyst Wire Dossier

DICLOXACILLIN SODIUM

DICLOXACILLIN SODIUM · Teva Pharmaceuticals USA, Inc.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for DICLOXACILLIN SODIUM, covering 2009-03-17 to 2022-09-23. Get the full timeline:

Most recent: FDA Approved: DICLOXACILLIN SODIUM — Original Application (Aurobindo Pharma Limited)

See pricing